spot_img

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies...

Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors

BENTONVILLE, Ark., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced a further strengthening of its Board of...

Top Stories

admin

Ettifos V2X Device, V2X-AIR, Now Fully Build America, Buy America Compliant,...

100% BABA-compliant and fully qualified for U.S. federal infrastructure programs Built in Houston, Texas, supporting American manufacturing and supply chain resilience Enables life-saving V2X safety applications—including collision warnings, work zone alerts, and intersection management Plug-and-play installation with smartphone app integration...
admin

Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with...

MINNEAPOLIS and BRISBANE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, announced one-year clinical outcomes for the...

Most Popular

People

Teads appoints Fernando Tassinari as Managing Director of LATAM to lead...

admin
People

Axogen, Inc. Reports Third Quarter 2025 Financial Results

admin
People

“Charm of Jiangsu ” extends invitation to Spain to enjoy woven...

admin
People

Turning Point of Tampa Expands Access to Mental Health Care with...

admin
People

Bread Financial Announces Pricing of Private Offering of $500 Million of...

admin
admin

Avacta presents first preclinical data from dual payload pre|CISION® medicines at...

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and maximize tumor controlLONDON and PHILADELPHIA, Oct. 25, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘Avacta’, ‘the Company’), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated...
admin

Boo-tiful Treats Await: Get Enchanted This Halloween with CASEKOO’s Magic Stand...

LOS ANGELES, Oct. 25, 2025 /PRNewswire/ -- Just in time for the spookiest season of the year, global creative powerhouse CASEKOO has unveiled a treat for tech enthusiasts and style mavens alike: the Titanium Glitter Magic Stand Pro Case for the new iPhone 17 Pro Max and Pro. This limited-edition masterpiece, finished...
spot_img

Category

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm...

admin

Telix Completes Acquisition of RLS (USA) Inc.

admin